CTHRC1 and prostate cancer: In particular, for the minor groupings, 162.9 (lung cancer) had six individuals with no significant association with Cthrc1 levels (p = 0.68, data not shown), and a personal history of a number of cancers (including malignant neoplasm of the bronchus and lung v10.11, cervical cancer v10.41, testicular cancer v10.47, ovarian cancer v10.43, laryngeal cancer v10.21, melanoma v10.82, prostate cancer v10.46, and rectal cancer v10.06) in the major groupings with 9 patients showed no significant association (p = 0.95, data not shown).